Summary Wuxi Pharmatech (Cayman) Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights WuXi Pharmatech (Cayman) (WuXi or ’the company’) is an outsourcing services provider to global pharmaceutical, biopharmaceutical and medical device companies. It offers a range of laboratory and manufacturing services. The company operates in the US, Europe, Asia and other countries. It is headquartered in Shanghai, China, and employed 8,837 people as on December 31, 2014.
Scope - Detailed information on Wuxi Pharmatech (Cayman) Inc required for business and competitor intelligence needs - A study of the major internal and external factors affecting Wuxi Pharmatech (Cayman) Inc in the form of a SWOT analysis - An in-depth view of the business model of Wuxi Pharmatech (Cayman) Inc including a breakdown and examination of key business segments - Intelligence on Wuxi Pharmatech (Cayman) Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Wuxi Pharmatech (Cayman) Inc, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy - Gain understanding of Wuxi Pharmatech (Cayman) Inc and the factors that influence its strategies. - Track strategic initiatives of the company and latest corporate news and actions. - Assess Wuxi Pharmatech (Cayman) Inc as a prospective partner, vendor or supplier. - Support sales activities by understanding your customers’ businesses better. - Stay up to date on Wuxi Pharmatech (Cayman) Inc’s business structure, strategy and prospects.
Our reports have been used by over 10K customers, including:
The lab balances and scales market is projected to grow at a CAGR of 3.7% during the forecast period The global lab balances and scales market is projected to reach USD 1.6 billion by 2023 from USD 1.3 billion in 2018, at a CAGR of 3.7%. The growth of this market is largely driven by factors such as increasingly stringent...
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Antifungal Drugs Market. The report analyses the Antifungal Drugs Market By Drug Type (Azoles, Echinocandins,...
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Electrophysiology Devices Market. The market on Electrophysiology Devices Market has been analyzed...
The global laboratory information management systems market is expected to reach US$ 2,168.1 Mn in 2025 from US$ 481.8 Mn in 2017. The market is estimated to grow with a CAGR of 20.9% from 2018-2025. Driving factors such as rising adoption of automation in laboratories and technological advancements in laboratory information management...
The global flow cytometry market is projected to grow at a CAGR of 8.1%. The global flow cytometry market is projected to reach USD 5.4 billion by 2023 from USD 3.7 billion in 2018, growing at a CAGR of 8.1% from 2018 to 2023. The key factors driving the growth of this market include technological advancements in flow cytometers,...
Increasing research activity in the pharmaceutical and biotechnology industries is expected to drive the overall growth of the laboratory mixers market. The laboratory mixers market is expected to grow from USD 1.1 billion in 2018 to USD 1.4 billion by 2023, at a CAGR of 4.4% during the forecast period. The laboratory mixers market is driven...
The rising adoption of third-party quality controls is expected to drive the overall growth of the molecular quality controls market. The molecular quality controls market is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The molecular quality controls...
238 pages •
By Roots Analysis Private Ltd.
• Oct 2018
INTRODUCTION In the recent past, cell and gene therapies have emerged as promising treatment options for a myriad of complex clinical conditions, including cancers and inherited disorders. Currently, more than 25 such advanced therapy medicinal products are available in the market; examples of recently approved therapies...
The US point-of-care diagnostics market is expected to generate revenues of around $11 billion by 2024, growing at a CAGR of more than 7% during 2018-2024. The emergence of wearable medical devices, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices in the US market. The growing...
Industrial workers and warfighters can perform at a higher level when wearing anexoskeleton. Exoskeletons can enable aerospace workers to work more efficiently whenbuilding or repairing airplanes. Industrial robots are very effective for ship buildingwhere heavy lifting can injure workers. Exoskeleton devices have the potential to be...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.